bioAffinity Technologies, Inc. Investing Cash Flow
bioAffinity Technologies, Inc. (BIAF) reported Investing Cash Flow of -$95.63 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$89.97K.
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$5.66K.
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.00.
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $3.65K.
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$60.57K.
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$79.08K.
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$2.21M.
- bioAffinity Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$219.99K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$89.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$95.63K 10-Q · filed 2026-08-07 | -$95.63K derived: sum of 3 quarters · filed 2026-08-07 | -$91.99K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$5.66K 10-Q · filed 2026-05-11 | -$5.66K derived: sum of 2 quarters · filed 2026-05-11 | -$2.02K derived: sum of 3 quarters · filed 2026-05-11 | -$15.45K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.65K derived: sum of 2 quarters · filed 2026-03-16 | -$9.78K derived: sum of 3 quarters · filed 2026-08-07 | -$60.57K 10-K · filed 2026-03-16 |
| 2025-09-30 | $3.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$9.78K derived: sum of 2 quarters · filed 2026-08-07 | -$60.57K 10-Q · filed 2025-11-14 | -$60.57K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$13.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$64.21K 10-Q · filed 2026-08-07 | -$64.21K derived: sum of 3 quarters · filed 2026-08-07 | -$73.62K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$50.79K 10-Q · filed 2026-05-11 | -$50.79K derived: sum of 2 quarters · filed 2026-05-11 | -$60.20K derived: sum of 3 quarters · filed 2026-05-11 | -$88.48K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$9.41K derived: sum of 2 quarters · filed 2026-03-16 | -$37.70K derived: sum of 3 quarters · filed 2026-03-16 | -$79.08K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$9.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$37.70K derived: sum of 2 quarters · filed 2025-11-14 | -$79.08K 10-Q · filed 2025-11-14 | -$65.64K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$28.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$69.67K 10-Q · filed 2025-08-14 | -$56.23K derived: sum of 3 quarters · filed 2025-08-14 | -$2.24M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$41.39K 10-Q · filed 2025-05-15 | -$27.95K derived: sum of 2 quarters · filed 2025-05-15 | -$2.21M derived: sum of 3 quarters · filed 2025-05-15 | -$2.22M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $13.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$2.17M derived: sum of 2 quarters · filed 2025-03-31 | -$2.18M derived: sum of 3 quarters · filed 2025-03-31 | -$2.21M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.19M derived: sum of 2 quarters · filed 2024-11-14 | -$2.22M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$3.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$36.17K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$32.31K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$219.99K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |